This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Why Accuray (ARAY) Hit a Five-Year High Today

NEW YORK (TheStreet) -- Accuray  (ARAY - Get Report) was rising 11% to $10.21 on Friday after the radiation oncology services provider reported its second-quarter earnings results. The stock hit a high of $10.71 as of 12:16 p.m., its highest point in nearly six years.

The company reported gross orders of $80.3 million, while total revenue increased 20% year-over-year to $93.6 million. Gross profit margin grew to 40.8%, while adjusted EBITDA reached $6.8 million. Accuray also adjusted its fiscal year 2014 guidance of total revenue to a range of $340 million to $350 million, up from its previous guidance of $325 million to $345 million, which it provided on Aug. 27, 2013 and reaffirmed on Nov. 7, 2013.

"The second quarter marks our fourth consecutive quarter of net order strength, driven by our improved commercial execution and customer focus.  We are pleased with our strong and improving operational performance during the first half of our fiscal year," said president and CEO Joshua H. Levine in the company's statement. "We remain focused on our strategic growth agenda and believe our focus on operational and commercial execution, coupled with fiscal discipline, will continue to create value for all of our stakeholders." ARAY Chart

ARAY data by YCharts

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ARAY $9.29 -0.11%
AAPL $123.70 -0.59%
FB $81.35 -1.10%
GOOG $546.84 -0.21%
YHOO $44.12 -0.71%


DOW 17,603.56 -172.56 -0.97%
S&P 500 2,054.25 -13.64 -0.66%
NASDAQ 4,866.5980 -34.2870 -0.70%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs